Biocon Ltd.
Snapshot View

View in App

Prices View details >>

198.80 -8.05 ▼-3.9%

24 March 2023, 04:01:00 PM
Volume: 500,372

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.biocon.com
Market Cap 23,867.93 Cr.
Enterprise Value(EV) 28,005.83 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 3.23 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 61.50 Trailing Twelve Months Ending 2022-12
Industry PE 31.87 Trailing Twelve Months Ending 2022-12
Book Value / Share 80.48 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.47 Calculated using Price: 198.80
Dividend Yield 0.25 Period Ending 2022-03
No. of Shares Subscribed 120.06 Cr. 1,200,600,000 Shares
FaceValue 5
Company Profile
The company is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.89%
1 Week
-1.49%
1 Month
-11.86%
3 Month
-25.57%
6 Month
-30.02%
1 Year
-41.92%
2 Year
-50.60%
5 Year
-30.40%
10 Year
+331.99%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.68 17.22 16.91 15.74 9.17 18.01 14.26 12.03 9.83
Return on Capital Employed (%) 15.75 15.30 14.33 12.83 9.21 16.12 14.35 10.56 8.30
Return on Assets (%) 8.47 8.72 8.25 7.83 4.77 9.26 6.94 5.24 4.03

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 3,027 3,271 4,034 4,838 5,181 6,098 6,706 7,627 8,433 9,628
Non Curr. Liab. 1,262 1,378 2,421 2,305 2,007 2,122 2,685 5,497 6,803 7,394
Curr. Liab. 1,380 1,555 1,666 1,678 2,141 3,039 4,008 4,170 3,828 4,125
Minority Int. 82 172 266 376 468 609 677 881 1,038 1,212
Equity & Liab. 5,751 6,375 8,387 9,197 9,796 11,868 14,076 18,215 20,101 22,359
Non Curr. Assets 3,112 3,813 4,416 5,149 5,648 6,979 8,751 10,614 11,718 12,311
Curr. Assets 2,639 2,563 3,971 4,048 4,149 4,889 5,325 7,548 8,382 10,048
Misc. Exp. not W/O
Total Assets 5,751 6,375 8,387 9,197 9,796 11,868 14,076 18,215 20,101 22,359

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 2,877 3,090 3,347 3,891 4,123 5,514 6,301 7,143 8,184 9,809
Other Income 56 53 84 157 206 414 508 605 690 288
Total Income 2,933 3,143 3,431 4,048 4,330 5,929 6,808 7,748 8,874 10,097
Total Expenditure -2,190 -2,394 -2,584 -2,912 -3,294 -4,391 -5,044 -5,841 -6,691 -7,703
PBIDT 743 749 847 1,137 1,035 1,538 1,765 1,907 2,183 2,395
Interest -2 -9 -29 -26 -62 -71 -65 -58 -68 -181
Depreciation -204 -221 -249 -277 -385 -448 -552 -715 -814 -962
Taxation -107 -96 -142 -162 -157 -212 -315 -222 -212 -231
Exceptional Items 105 161 195 68 13 -111 -329
PAT 431 528 609 688 453 1,003 900 846 772 692
Minority Interest -17 -31 -59 -76 -81 -97 -123 -106 -123 -124
Share Associate -180
Other Related Items
Consolidated Net Profit 414 497 550 612 372 905 748 741 648 388
Adjusted EPS 3 4 5 5 3 8 6 6 5 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 471 561 211 371 640 662 1,155 1,283 1,160 1,177
Cash Fr. Inv. -376 -938 -509 -1,142 -499 -684 -714 -1,559 -3,625 -1,699
Cash Fr. Finan. -9 426 186 1,068 -178 -240 -242 388 2,564 242
Net Change 87 49 -112 297 -36 -262 199 112 99 -280
Cash & Cash Eqvt 474 557 463 758 710 449 659 825 897 654

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 60.67 60.67 60.64 60.64 60.64 60.64 60.64 60.64 60.64
Public 39.33 39.33 39.36 39.36 39.36 39.36 39.36 39.36 39.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 21 Mar 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Investor Meetings
Mon, 20 Mar 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Arohi Asset Management Pte Ltd
Mon, 20 Mar 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Investor Meeting

Technical Scans View Details >>

Fri, 24 Mar 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 233,407.31 972.80 -0.5%
Divi's Laboratories Ltd. 74,497.12 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. 74,309.73 4,462.75 +0.3%
Cipla Ltd. 70,787.11 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. 61,557.09 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. 51,379.40 1,517.75 -0.9%
Zydus Lifesciences Ltd. 48,636.41 480.50 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 55.42 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.11 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.39 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 26.83 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.33 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.81 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.60 480.50 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.22 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.38 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 3.12 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.82 480.50 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.50 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.50 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.50 -0.4%

FAQ's On Biocon Ltd.

What is Biocon share price?
Can I buy Biocon shares now?
What is the Dividend Yield of Biocon?
What is the Market Cap of Biocon?
What are the key metrics to analyse Biocon?
What is the 52 Week High and Low of Biocon?
What is the trend of Biocon share price?